{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:11Z","timestamp":1786997891367,"version":"build-2736575974"},"reference-count":93,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-24-00007"],"award-info":[{"award-number":["14-24-00007"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2016.01.010","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T16:31:42Z","timestamp":1452875502000},"page":"1006-1011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The key role of rubella virus glycoproteins in the formation of immune response, and perspectives on their use in the development of new recombinant vaccines"],"prefix":"10.1016","volume":"34","author":[{"given":"Ekaterina K.","family":"Petrova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Dmitrieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina A.","family":"Trifonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai A.","family":"Nikitin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Karpova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2016.01.010_bib0470","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1590\/S1020-49892003001000005","article-title":"Rubella and congenital rubella syndrome: global update","volume":"14","author":"Robertson","year":"2003","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0475","first-page":"169","article-title":"Accelerated control of rubella and prevention of congenital rubella syndrome. Brazil","volume":"77","author":"WHO (World Health Organization)","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.010_bib0480","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ajmg.a.30225","article-title":"Pregnancy outcome following rubella vaccination: a prospective controlled study","volume":"130A","author":"Bar-Oz","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"9415","key":"10.1016\/j.vaccine.2016.01.010_bib0485","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)15897-2","article-title":"Rubella","volume":"363","author":"Banatvala","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0490","series-title":"Current issues in molecular virology\u2014viral genetics and biotechnological applications","article-title":"Vaccines and antiviral agents","author":"Hongxuan","year":"2013"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0495","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.45.2.110","article-title":"Rubella-associated arthritis. I. Comparative study of joint manifestation associated with natural rubella infection and RA 27\/3.rubella immunization","volume":"45","author":"Tingle","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0500","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0264-410X(95)00096-J","article-title":"Absence of an association between rubella vaccination and arthritis in underimmune postpartum women","volume":"13","author":"Slater","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0505","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(96)12031-6","article-title":"Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women","volume":"349","author":"Tingle","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0510","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jama.1997.03550070043036","article-title":"Risk of chronic arthropathy among women after rubella vaccination","volume":"278","author":"Ray","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0515","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/art.1780390913","article-title":"Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines: a review of 124 claims submitted to the National Vaccine Injury Compensation Program","volume":"39","author":"Weibel","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2016.01.010_bib0520","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000150543","article-title":"Neurological aspects of rubella virus infection","volume":"40","author":"Frey","year":"1997","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0525","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/pgmj.67.786.375","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with rubella","volume":"67","author":"Atkins","year":"1991","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0530","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0031-3955(16)36909-7","article-title":"Rubella and mumps vaccines","volume":"37","author":"Bakshi","year":"1990","journal-title":"Pediatr Clin North Am"},{"issue":"28\/29","key":"10.1016\/j.vaccine.2016.01.010_bib0535","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/S0264-410X(01)00122-0","article-title":"MMR vaccine in HIV-infected children-potential hazards?","volume":"19","author":"Goon","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.010_bib0540","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1128\/JCM.30.9.2323-2329.1992","article-title":"Cellular and humoral immune responses to rubella virus structural proteins E1 and E2","volume":"309","author":"Chaye","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.010_bib0545","first-page":"335","article-title":"Comparison of immune response to rubella virus proteins in early and late natural infections","volume":"12","author":"Nates","year":"1989","journal-title":"Microbiologica"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.010_bib0550","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/JVI.57.3.893-898.1986","article-title":"Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies","volume":"57","author":"Green","year":"1986","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2016.01.010_bib0555","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.1128\/JVI.01390-12","article-title":"Cryo-electron tomography of rubella virus","volume":"86","author":"Battisti","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.010_bib0560","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0042-6822(90)90476-8","article-title":"Sequence of genome RNA of rubella virus: evidence for genetic rearrangement during togavirus evolution","volume":"177","author":"Dominguez","year":"1990","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.010_bib0565","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ccr.2008.04.002","article-title":"Mitochondrial p32 is a critical mediator of ARF-induced apoptosis","volume":"13","author":"Itahana","year":"2008","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0570","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/JVI.51.2.354-358.1984","article-title":"The gene order for rubella virus structural proteins is NH2-C-E2\u2013El-COOH","volume":"51","author":"Oker-Blom","year":"1984","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.010_bib0575","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0042-6822(83)90471-3","article-title":"Immunochemical identification of rubella virus hemagglutinin","volume":"126","author":"Waxham","year":"1983","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.010_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01340535","article-title":"Degradation of rubella virus envelope components","volume":"65","author":"Ho-Terry","year":"1980","journal-title":"Arch Virol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.01.010_bib0585","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01310807","article-title":"The role of glycosylation on haemagglutination and immunological reactivity of rubella virus","volume":"79","author":"Ho-Terry","year":"1984","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.010_bib0590","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/clinids\/7.Supplement_1.S133","article-title":"A model of the structural organization of rubella virions","volume":"7","author":"Waxham","year":"1985","journal-title":"Rev Infect Dis"},{"issue":"7433","key":"10.1016\/j.vaccine.2016.01.010_bib0595","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature11741","article-title":"Functional and evolutionary insight from the crystal structure of rubella virus protein E1","volume":"493","author":"DuBois","year":"2013","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.vaccine.2016.01.010_bib0600","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1128\/JVI.74.14.6637-6642.2000","article-title":"Mutations in the E1 hydrophobic domain of rubella virus impair virus infectivity but not virus assembly","volume":"74","author":"Qiu","year":"2000","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.010_bib0605","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.vaccine.2016.01.010_bib0610","doi-asserted-by":"crossref","first-page":"8747","DOI":"10.1128\/JVI.72.11.8747-8755.1998","article-title":"Effects of mutations in the rubella virus E1 glycoprotein on E1\u2013E2 interaction and membrane fusion activity","volume":"72","author":"Yang","year":"1998","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.010_bib0615","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/JCM.21.3.449-451.1985","article-title":"Antibody response to individual rubella virus proteins in congenital and other rubella virus infections","volume":"21","author":"Katow","year":"1985","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2016.01.010_bib0620","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1128\/JCM.34.9.2210-2218.1996","article-title":"Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals","volume":"34","author":"Mitchell","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.01.010_bib0625","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0166-0934(85)90135-1","article-title":"E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody","volume":"12","author":"Trudel","year":"1985","journal-title":"J Virol Methods"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.01.010_bib0630","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01310962","article-title":"Monoclonal antibodies directed to E1 glycoprotein of rubella virus","volume":"83","author":"Umino","year":"1985","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.010_bib0635","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinids\/7.Supplement_1.S150","article-title":"Structure and function of the rubella virus proteins","volume":"7","author":"Dorsett","year":"1985","journal-title":"Clin Infect Dis"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.01.010_bib0640","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01378973","article-title":"Rubella virus haemagglutinin: association with a single virion glycoprotein","volume":"84","author":"Ho-Terry","year":"1985","journal-title":"Arch Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2016.01.010_bib0645","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1099\/0022-1317-68-7-2007","article-title":"Synergistic neutralization of rubella virus by monoclonal antibodies to viral haemagglutinin","volume":"68","author":"Gerna","year":"1987","journal-title":"J Gen Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.01.010_bib0650","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01314152","article-title":"Immunological characterization of the rubella E1 glycoprotein","volume":"90","author":"Ho-Terry","year":"1986","journal-title":"Arch Virol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.01.010_bib0655","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01322168","article-title":"Localization of the rubella E1 epitopes","volume":"98","author":"Terry","year":"1988","journal-title":"Arch Virol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.01.010_bib0660","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01311295","article-title":"Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis","volume":"110","author":"Lozzi","year":"1990","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0665","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/JVI.67.2.961-968.1993","article-title":"An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain","volume":"67","author":"Wolinsky","year":"1993","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2016.01.010_bib0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/vim.2014.0021","article-title":"R237 and H238 are key amino acids in the rubella virus E1 neutralization epitope","volume":"27","author":"Li","year":"2014","journal-title":"Viral Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.010_bib0675","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/CDLI.7.6.964-966.2000","article-title":"Evaluation of antibodies against rubella virus neutralizing domain for determination of immune status","volume":"7","author":"Cordoba","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0680","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0042-6822(92)90572-7","article-title":"Localization of the neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus","volume":"189","author":"Chaye","year":"1992","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.vaccine.2016.01.010_bib0685","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1128\/JVI.65.8.3986-3994.1991","article-title":"Monoclonal antibody-defined epitope map of expressed rubella virus protein domains","volume":"65","author":"Wolinsky","year":"1991","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.010_bib0690","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/CDLI.4.4.493-495.1997","article-title":"Presence of a neutralizing domain in an isolate of rubella virus in Cordoba, Argentina","volume":"4","author":"Cordoba","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.010_bib0695","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0042-6822(85)90104-7","article-title":"Detailed immunological analysis of the structural polypeptides of rubella virus using monoclonal antibodies","volume":"143","author":"Waxham","year":"1985","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.010_bib0700","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/bip.360310607","article-title":"Structure and antigenic activity of rubella E1 glycoprotein synthetic peptides","volume":"31","author":"Neri","year":"1991","journal-title":"Biopolymers"},{"issue":"3","key":"10.1016\/j.vaccine.2016.01.010_bib0705","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF01718431","article-title":"Sequence variation and biological activity of rubella virus isolates","volume":"140","author":"Londesborough","year":"1995","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007050170186","article-title":"Rubella virus glycoprotein interaction with the endoplasmic reticulum calreticulin and calnexin","volume":"146","author":"Nakhasi","year":"2001","journal-title":"Arch Virol"},{"issue":"1\u20134","key":"10.1016\/j.vaccine.2016.01.010_bib0715","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01316909","article-title":"Possibility of reinfection after immunization with RA 27\/3 live attenuated rubella virus","volume":"129","author":"Cusi","year":"1993","journal-title":"Arch Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.01.010_bib0720","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.1128\/JVI.71.10.7670-7680.1997","article-title":"Characterization of an endoplasmic reticulum retention signal in the rubella virus E1 glycoprotein","volume":"71","author":"Hobman","year":"1997","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2016.01.010_bib0725","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1128\/JVI.64.11.5500-5509.1990","article-title":"The E2 signal sequence of rubella virus remains part of the capsid protein and confers membrane association in vitro","volume":"64","author":"Suomlainen","year":"1990","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.010_bib0730","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1128\/JVI.75.4.1978-1983.2001","article-title":"Rubella virus E2 signal peptide is required for perinuclear localization of capsid protein and virus assembly","volume":"75","author":"Law","year":"2001","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.01.010_bib0735","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1099\/vir.0.82035-0","article-title":"Rubella virus pseudotypes and a cell\u2013cell fusion assay as tools for functional analysis of the rubella virus E2 and E1 envelope glycoproteins","volume":"87","author":"Claus","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0740","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000214861","article-title":"Effects of E1 and E2 glycosylation on specific membrane fusion in rubella virus strain JR23","volume":"52","author":"Wu","year":"2009","journal-title":"Intervirology"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0745","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jmv.1890190203","article-title":"Antibody response to the rubella virus structural proteins in infants with congenital rubella syndrome","volume":"19","author":"de Mazancourt","year":"1986","journal-title":"J Med Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2016.01.010_bib0750","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1128\/JVI.66.11.6788-6793.1992","article-title":"Identification of T-cell epitopes on E2 protein of rubella virus, as recognized by human T-cell lines and clones","volume":"66","author":"Ou","year":"1992","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2016.01.010_bib0755","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3201\/eid0912.030242","article-title":"Global distribution of rubella virus genotypes","volume":"9","author":"Zheng","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0760","first-page":"209","article-title":"Update of standard nomenclature for wild-type rubella viruses","volume":"82","author":"WHO (World Health Organization)","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0765","first-page":"337","article-title":"Rubella virus nomenclature update","volume":"88","author":"WHO (World Health Organization)","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0770","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1099\/vir.0.036293-0","article-title":"Immunogenic compositions assembled from tobacco mosaic virus-generated spherical particle platforms and foreign antigens","volume":"93","author":"Karpova","year":"2012","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.010_bib0775","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1017\/S1431927613000597","article-title":"Examination of biologically active nanocomplexes by Nanoparticle Tracking Analysis","volume":"19","author":"Nikitin","year":"2013","journal-title":"Microsc Microanal"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0780","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/oxfordjournals.aje.a120757","article-title":"A new attenuated rubella virus grown in human fibroblasts: evidence for reduced nasopharyngeal excretion","volume":"86","author":"Plotkin","year":"1967","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0785","series-title":"Expanded program on immunization","first-page":"549","author":"Ze","year":"2001"},{"issue":"l3","key":"10.1016\/j.vaccine.2016.01.010_bib0790","first-page":"30","article-title":"General review of clinical trials of rubella vaccines","volume":"7","author":"Freestone","year":"1972","journal-title":"Postgrad Med J"},{"issue":"RR-3","key":"10.1016\/j.vaccine.2016.01.010_bib0795","first-page":"1","article-title":"Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Marin","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0800","first-page":"CD004407","article-title":"Vaccines for measles, mumps and rubella in children","volume":"2","author":"Demicheli","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0805","series-title":"Rubella vaccines. Summary of WHO position paper published in WER July 2011","author":"WHO (World Health Organization)","year":"2011"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0810","first-page":"218","article-title":"Transient arthritis after rubella vaccination","volume":"118","author":"Cooper","year":"1969","journal-title":"Am J Dis Child"},{"issue":"8055","key":"10.1016\/j.vaccine.2016.01.010_bib0815","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(78)90001-6","article-title":"Rubella infection and diabetes mellitus","volume":"311","author":"Menser","year":"1978","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.010_bib0820","first-page":"1053","article-title":"Measles\u2013mumps\u2013rubella vaccination induced thrombocytopenia: a case report and review of the literature","volume":"45","author":"Owatanapanich","year":"2014","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0825","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jmv.1890440214","article-title":"Expression and characterization of a soluble rubella virus E1 envelope protein","volume":"44","author":"Seto","year":"1995","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0830","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0168-1702(00)00170-2","article-title":"Rubella virus nonstructural proteins 2 is a minor immunogen","volume":"68","author":"Hofmann","year":"2000","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2016.01.010_bib0835","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.vaccine.2004.06.030","article-title":"A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate","volume":"23","author":"Perrenoud","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.01.010_bib0840","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0042-6822(90)90385-5","article-title":"Processing and intracellular transport of the rubella virus structural proteins in COS cells","volume":"178","author":"Hobman","year":"1990","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0845","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0042-6822(92)90929-J","article-title":"The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein","volume":"190","author":"Qiu","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0850","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1242\/jcs.109.6.1195","article-title":"Cell surface expression of a functional rubella virus E1 glycoprotein by addition of a GPI anchor","volume":"109","author":"Bernasconi","year":"1996","journal-title":"J Cell Sci"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0855","series-title":"The Vth Vavilov Society Congress of Geneticists and Breeders","first-page":"376","article-title":"Construction of recombinant virus-like nanoparticles carrying epitopes of rubella and influenza viruses","author":"Kotlyarov","year":"2009"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0860","unstructured":"Kotljarov R, Mardanova E, Ravin N, Sveshnikov P, Skrjabin K. Recombinant viral vector for producing red rot viral protein E1 in plants (versions) and red rot viral protein E1 expression system in plant cells (versions). Russian patent \u2116 2390563; 2008."},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0865","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1006\/viro.1994.1379","article-title":"Assembly of rubella virus structural proteins into virus-like particles in transfected cells","volume":"202","author":"Hobman","year":"1994","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2016.01.010_bib0870","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1128\/JVI.68.6.4086-4091.1994","article-title":"Expression and characterization of virus-like particles containing rubella virus structural proteins","volume":"68","author":"Qiu","year":"1994","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0875","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/viro.1999.9857","article-title":"Secretion of rubella virions and virus-like particles in cultured epithelial cells","volume":"261","author":"Garbutt","year":"1999","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0880","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0003-2697(02)00217-8","article-title":"A technique for isolation of rubella virus-like particles by sucrose gradient ultracentrifugation using Coomassie brilliant blue G crystals","volume":"308","author":"Giessauf","year":"2002","journal-title":"Anal Biochem"},{"issue":"10","key":"10.1016\/j.vaccine.2016.01.010_bib0885","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00705-005-0538-5","article-title":"Preparation of immunoblot test stripes from a Rubella virus-like particles dye crystal complex as antigen","volume":"150","author":"Giessauf","year":"2005","journal-title":"Arch Virol"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2016.01.010_bib0890","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0264-410X(98)00371-5","article-title":"Development of a rubella virus DNA vaccine","volume":"17","author":"Pougatcheva","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.01.010_bib0895","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.96.5.1915","article-title":"Native display of complete foreign protein domains on the surface of hepatitis B virus capsids","volume":"96","author":"Kratz","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2016.01.010_bib0900","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000050037","article-title":"HBV core particles as a carrier for B cell\/T cell epitopes","volume":"44","author":"Pumpens","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0905","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/CVI.00533-13","article-title":"Chimeric derivatives of hepatitis B core particles carrying major epitopes of the rubella virus E1 glycoprotein","volume":"20","author":"Skrastina","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.01.010_bib0910","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1099\/vir.0.024356-0","article-title":"Thermal transition of native tobacco mosaic virus and RNA-free viral proteins into spherical nanoparticles","volume":"92","author":"Atabekov","year":"2011","journal-title":"J Gen Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2016.01.010_bib0915","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/09205063.2014.946877","article-title":"Proteins immobilization on the surface of modified plant viral particles coated with hydrophobic polycations","volume":"25","author":"Nikitin","year":"2014","journal-title":"J Biomater Sci Polym Ed"},{"issue":"8","key":"10.1016\/j.vaccine.2016.01.010_bib0920","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/07391102.2013.816868","article-title":"Complexes assembled from TMV-derived spherical particles and entire virions of heterogeneous nature","volume":"32","author":"Trifonova","year":"2014","journal-title":"J Biomol Struct Dyn"},{"issue":"50","key":"10.1016\/j.vaccine.2016.01.010_bib0925","doi-asserted-by":"crossref","first-page":"20105","DOI":"10.1073\/pnas.1316681110","article-title":"Rubella virus capsid protein structure and its role in virus assembly and infection","volume":"110","author":"Prasad","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.01.010_bib0930","series-title":"Vaccines","author":"Plotkin","year":"2013"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T15:43:34Z","timestamp":1654098214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16000293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":93,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X16000293"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The key role of rubella virus glycoproteins in the formation of immune response, and perspectives on their use in the development of new recombinant vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}